6.70
                                            전일 마감가:
              $6.66
            열려 있는:
              $6.67
            하루 거래량:
                13,696
            Relative Volume:
              0.19
            시가총액:
                $155.73M
            수익:
              -
            순이익/손실:
              -
            주가수익비율:
              -
            EPS:
                -
            순현금흐름:
                -
            1주 성능:
              -7.84%
            1개월 성능:
              -4.01%
            6개월 성능:
                -36.37%
            1년 성능:
              -14.43%
            Actuate Therapeutics Inc Stock (ACTU) Company Profile
명칭
                  
                      Actuate Therapeutics Inc
                    
                전화
                  
                      847-986-4190
                    
                주소
                  
                      1751 RIVER RUN, FORT WORTH
                    
                ACTU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ACTU
                            
                             
                        Actuate Therapeutics Inc 
                           | 
                    6.70 | 154.80M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-08-26 | 개시 | B. Riley Securities | Buy | 
| 2025-04-22 | 개시 | Craig Hallum | Buy | 
| 2025-03-17 | 개시 | H.C. Wainwright | Buy | 
Actuate Therapeutics Inc 주식(ACTU)의 최신 뉴스
Why Actuate Therapeutics Inc. stock could benefit from AI revolutionExit Point & Pattern Based Trade Signal System - newser.com
Using R and stats models for Actuate Therapeutics Inc. forecasting2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Real time scanner hits for Actuate Therapeutics Inc. explainedWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Actuate Therapeutics Inc. stock performs in high volatility markets2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
What indicators show strength in Actuate Therapeutics Inc.Global Markets & Long-Term Safe Investment Plans - newser.com
How Actuate Therapeutics Inc. stock compares to market leadersWeekly Profit Analysis & Community Supported Trade Ideas - newser.com
Is it time to cut losses on Actuate Therapeutics Inc.July 2025 WrapUp & Entry Point Strategy Guides - newser.com
What’s next for Actuate Therapeutics Inc. stock priceEarnings Growth Report & Entry Point Strategy Guides - newser.com
What makes Actuate Therapeutics Inc. stock attractive to growth fundsGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-11-01 09:18:34 - newser.com
Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.Earnings Summary Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-10-31 03:58:11 - newser.com
Is Actuate Therapeutics Inc. building a consolidation baseExit Point & AI Driven Stock Movement Reports - newser.com
How Actuate Therapeutics Inc. stock benefits from tech adoptionEarnings Recap Summary & Daily Stock Trend Watchlist - newser.com
Is Actuate Therapeutics Inc. stock gaining market shareStop Loss & Weekly Watchlist for Hot Stocks - fcp.pa.gov.br
Actuate Therapeutics shares sink on pricing of $15M public offering of common stock - MSN
Is Actuate Therapeutics Inc. stock near bottom after decline2025 Major Catalysts & Stock Portfolio Risk Control - fcp.pa.gov.br
EMA gives OMPD to Actuate’s pancreatic cancer therapy - MSN
Published on: 2025-10-27 18:21:51 - newser.com
Strategies to average down on Actuate Therapeutics Inc.Bond Market & Real-Time Stock Price Movement Reports - newser.com
Actuate Therapeutics Inc (ACTU) 재무 분석
        Actuate Therapeutics Inc (ACTU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
    
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):